Nurformix PLC's (LON:NFX) Dr Anne Brindley talks to Proactive London after being appointed at the end of 2020.
Brindley has worked in the pharma industry for over 30 years and believes Nuformix has great potential and value in its assets as well as expertise.
She goes on to explain why it is an important time for Nuformix, determining how to get optimal value through R&D, business development and licensing opportunities.